Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy
Abstract An appropriate antibiotherapy is crucial for the safety and recovery of patients. Depending on the clinical conditions of patients, the required dose to effectively eradicate an infection may vary. An inadequate dosing not only reduces the efficacy of the antibiotic, but also promotes the e...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bc35e50ee17a4018acd7b593716960cb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:bc35e50ee17a4018acd7b593716960cb |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:bc35e50ee17a4018acd7b593716960cb2021-12-02T15:05:09ZClinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy10.1038/s41598-017-03338-z2045-2322https://doaj.org/article/bc35e50ee17a4018acd7b593716960cb2017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-03338-zhttps://doaj.org/toc/2045-2322Abstract An appropriate antibiotherapy is crucial for the safety and recovery of patients. Depending on the clinical conditions of patients, the required dose to effectively eradicate an infection may vary. An inadequate dosing not only reduces the efficacy of the antibiotic, but also promotes the emergence of antimicrobial resistances. Therefore, a personalized therapy is of great interest for improved patients’ outcome and will reduce in long-term the prevalence of multidrug-resistances. In this context, on-site monitoring of the antibiotic blood concentration is fundamental to facilitate an individual adjustment of the antibiotherapy. Herein, we present a bioinspired approach for the bedside monitoring of free accessible ß-lactam antibiotics, including penicillins (piperacillin) and cephalosporins (cefuroxime and cefazolin) in untreated plasma samples. The introduced system combines a disposable microfluidic chip with a naturally occurring penicillin-binding protein, resulting in a high-performance platform, capable of gauging very low antibiotic concentrations (less than 6 ng ml−1) from only 1 µl of serum. The system’s applicability to a personalized antibiotherapy was successfully demonstrated by monitoring the pharmacokinetics of patients, treated with ß-lactam antibiotics, undergoing surgery.R. BruchC. ChatelleA. KlingB. RebmannS. WirthS. SchumannW. WeberC. DincerG. UrbanNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q R. Bruch C. Chatelle A. Kling B. Rebmann S. Wirth S. Schumann W. Weber C. Dincer G. Urban Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy |
description |
Abstract An appropriate antibiotherapy is crucial for the safety and recovery of patients. Depending on the clinical conditions of patients, the required dose to effectively eradicate an infection may vary. An inadequate dosing not only reduces the efficacy of the antibiotic, but also promotes the emergence of antimicrobial resistances. Therefore, a personalized therapy is of great interest for improved patients’ outcome and will reduce in long-term the prevalence of multidrug-resistances. In this context, on-site monitoring of the antibiotic blood concentration is fundamental to facilitate an individual adjustment of the antibiotherapy. Herein, we present a bioinspired approach for the bedside monitoring of free accessible ß-lactam antibiotics, including penicillins (piperacillin) and cephalosporins (cefuroxime and cefazolin) in untreated plasma samples. The introduced system combines a disposable microfluidic chip with a naturally occurring penicillin-binding protein, resulting in a high-performance platform, capable of gauging very low antibiotic concentrations (less than 6 ng ml−1) from only 1 µl of serum. The system’s applicability to a personalized antibiotherapy was successfully demonstrated by monitoring the pharmacokinetics of patients, treated with ß-lactam antibiotics, undergoing surgery. |
format |
article |
author |
R. Bruch C. Chatelle A. Kling B. Rebmann S. Wirth S. Schumann W. Weber C. Dincer G. Urban |
author_facet |
R. Bruch C. Chatelle A. Kling B. Rebmann S. Wirth S. Schumann W. Weber C. Dincer G. Urban |
author_sort |
R. Bruch |
title |
Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy |
title_short |
Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy |
title_full |
Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy |
title_fullStr |
Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy |
title_full_unstemmed |
Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy |
title_sort |
clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/bc35e50ee17a4018acd7b593716960cb |
work_keys_str_mv |
AT rbruch clinicalonsitemonitoringofßlactamantibioticsforapersonalizedantibiotherapy AT cchatelle clinicalonsitemonitoringofßlactamantibioticsforapersonalizedantibiotherapy AT akling clinicalonsitemonitoringofßlactamantibioticsforapersonalizedantibiotherapy AT brebmann clinicalonsitemonitoringofßlactamantibioticsforapersonalizedantibiotherapy AT swirth clinicalonsitemonitoringofßlactamantibioticsforapersonalizedantibiotherapy AT sschumann clinicalonsitemonitoringofßlactamantibioticsforapersonalizedantibiotherapy AT wweber clinicalonsitemonitoringofßlactamantibioticsforapersonalizedantibiotherapy AT cdincer clinicalonsitemonitoringofßlactamantibioticsforapersonalizedantibiotherapy AT gurban clinicalonsitemonitoringofßlactamantibioticsforapersonalizedantibiotherapy |
_version_ |
1718388918756311040 |